PacBio stock falls 16% post-market after Q3 revenue miss

jurgenfr Shares of PacBio ( NASDAQ: PACB ) fell 16% in post-market trading Thursday after the company reported lower-than-expected Q3 revenue. The sequencing solutions company reported Q3 revenue of $40M , down from $55.7M the year prior, attributing the drop in part to macroeconomic conditions for capital.